New research in the New England Journal of Medicine finds Rimegepant successfully relieves pain and other symptoms, including nausea and light sensitivity.
New Help for Migraines
July 12, 2019
Thank you medical professionals! Stay safe and stay strong!
We are grateful for the hard work of hospital staff, first responders, and the researchers and patient volunteers who are making clinical trials for a COVID-19 vaccine happen right now!
Sign-up for our email updates.
Minnesota becomes first state to screen all infants for cytomegalovirus (CMV)
According to the CDC, about 1 out of every 200 babies is born with congenital CMV and about 1 out of 5 of these babies will have birth defects or other long-term health problems. Clinical Research Institute is conducting a research study for a vaccine to protect against CMV in women age 16 to 40.
Read more.
MINNEAPOLIS, MN
Clinical Research Institute, Inc.
825 Nicollet Mall, Suite 1135
Minneapolis, MN 55402
Ph: 612-333-2200
Fax: 612-349-6478
Copyright © 2023 Clinical Research Institute, Inc. All rights reserved. Privacy Policy Terms and Conditions Employment Site Map Developed by Vivid Image
